Arsenal Capital Partners Announces the Formation of its Digital and AI Advisory Board
NEW YORK, Oct. 9, 2024 /PRNewswire/ -- Arsenal Capital Partners ("Arsenal"), a leading private equity firm specializing in building technology-rich,...
News
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results
WARSAW, Ind., Oct. 9, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter...
AHEAD Achieves AWS Healthcare Competency Status
Recognizing AHEAD's technical expertise in delivering seamless solutions for clients on the AWS platform CHICAGO, Oct. 9, 2024 /PRNewswire/ --...
WELL Health Announces Positive Findings from AI Scribe Evaluation Study Conducted by OntarioMD
OntarioMD's independent study of AI scribes, which included WELL's AI Voice solution and several others, found over a 70% reduction...
SAIGroup Welcomes High Growth Health Company Investor Michael Healy as Operating Partner
Senior investment partner is responsible for investment and acquisition activity across healthcare and additional vertical sectors PALO ALTO, Calif., Oct....
Dignify Therapeutics welcomes leading healthcare entrepreneurs Howard Palefsky and Neil Kurtz, MD to its Board of Directors
RESEARCH TRIANGLE PARK, N.C., Oct. 9, 2024 /PRNewswire/ -- Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and...
Smile Digital Health Joins NCQA’s Digital Content Services Early Adopters Program to Support the Digitization of HEDIS Scores
Smile Digital Health is contributing insights and best practices for the digitization of HEDIS® scores as part of the NCQA...
Lexaria’s GLP-1 Human Pilot Study #3 Begins Dosing
DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC / ACCESSWIRE / October 9, 2024...
Institute for Healthcare Advancement Announces Two Platforms to Help Amplify Health Literacy and Health Equity Adoption in Healthcare During Health Literacy Month
Both IHA platforms empower individuals with health literacy knowledge and skills to help those they serve make informed health decisions...
Hurricane Helene and Milton Devastation: Supporting Impacted Healthcare Professionals and Medical Facilities
OMAHA, NE / ACCESSWIRE / October 9, 2024 / As a company focused on supporting healthcare professionals, medical facilities, and...
MedCana Highlights Recent Acquisitions and the Multiple Cannabis Licenses Associated with Each
The licenses will add $1.6 million to our total Assets for the 3rd Quarter. AUSTIN, TX / ACCESSWIRE / October...
180 Life Sciences Corp. Regains Compliance with Nasdaq’s Minimum Stockholders’ Equity Rule and Expands into the Global iGaming Sector
PALO ALTO, CA / ACCESSWIRE / October 9, 2024 / 180 Life Sciences Corp. (NASDAQ:ATNF) (the "Company" or "180"), is...
Releaf & SOMAÍ Unite in Exclusive UK Cannabis Deal
Releaf® Announces Partnership with SOMAÍ Pharmaceuticals to Bring Innovative Cannabis Solutions to UK Patients NOTTINGHAM, ENGLAND / ACCESSWIRE / October...
Releaf & SOMAÍ Unite in Exclusive UK Cannabis Deal
Releaf® Announces Partnership with SOMAÍ Pharmaceuticals to Bring Innovative Cannabis Solutions to UK Patients NOTTINGHAM, ENGLAND / ACCESSWIRE / October...
Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors
– Data show that p300 KAT inhibitor KB-9558 was highly selective against human papillomavirus (HPV) oncoproteins E6 and E7, and...
Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India
Sonnet to receive $1.0 million in upfront payment and up to an additional$1.0 million in milestone payments with a royalty...
Entourage Health Provides Company Update
TORONTO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a...
Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit
MIAMI, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...
SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit
DENVER, Oct. 09, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary...
Aprea Therapeutics Engages Philippe Pultar, MD to Serve as Senior Medical Advisor and Lead WEE1 Clinical Development
DOYLESTOWN, Pa., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical...